As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at software development stocks, starting ...

Global content delivery network Akamai has released software for running vaccination registration websites, with Vaccine Edge claimed to provide the needed delivery, security and waiting room logic.

Akamai scored a victory in its patent battle with competitor Limelight last week, as a jury ruled that Limelight had infringed Akamai's patents. The jury awarded Akamai $46 million in damages, plus ...

Let’s dig into the relative performance of Akamai (NASDAQ:AKAM) and its peers as we unravel the now-completed Q2 software development earnings season. As legendary VC investor Marc Andreessen says, ...

(MENAFN- GlobeNewsWire - Nasdaq) New Referral-Based Program Offers ISVs Path to Growth on Akamai's Globally Distributed Cloud Platform CAMBRIDGE, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Akamai ...

A new Akamai report on overcoming deployment obstacles in segmentation offers healthcare organizations a blueprint for zero-trust architecture that can thwart debilitating cyberattacks. Healthcare and ...

(RTTNews) - Akamai Technologies (AKAM) has launched ISV Catalyst, a new referral-based partner program aimed at helping independent software vendors grow on its globally distributed cloud platform.

Akamai stock tumbled 14% in Friday’s trading following its Q3 earnings report, which largely met expectations but raised concerns with a weaker Q4 guidance. Moreover, the continued decline in the ...